Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Johns Hopkins University · Johns Hopkins Hospital
Indexed incrossrefpubmed
Abstract
PURPOSE: We assessed outcomes of men with prostate cancer enrolled in active surveillance. PATIENTS AND METHODS: Since 1995, a total of 769 men diagnosed with prostate cancer have been followed prospectively (median follow-up, 2.7 years; range, 0.01 to 15.0 years) on active surveillance. Enrollment criteria were for very-low-risk cancers, defined by clinical stage (T1c), prostate-specific antigen density
Citation impact
593
total citations
- FWCI
- 57.20
- Percentile
- 100%
- References
- 33
Citations per year
Authors
8- JJJeffrey J. TosoianCorresponding
Johns Hopkins University, Johns Hopkins Hospital
- BJBruce J. Trock
Johns Hopkins University, Johns Hopkins Hospital
- PLPatricia Landis
Johns Hopkins University, Johns Hopkins Hospital
- ZFZhaoyong Feng
Johns Hopkins University, Johns Hopkins Hospital
- JIJonathan I. Epstein
Johns Hopkins University, Johns Hopkins Hospital
Topics & keywords
Topics
Keywords
- Medicine
- Prostate cancer
- Biopsy
- Cancer
- Stage (stratigraphy)
- Prostate
- Prostate-specific antigen
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.